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T inhibits HIV viral entry to human susceptive cells. As compared with cyanovirin-N, AH binds more specifically to the high mannose-type saccharide chains (HMTG) of HIV gp120 protein. This lectin is a small protein of 114 amino acid residues, being arranged in a unique sequence repeated by three times tandemly. To reveal the structure of the specific binding, X-ray analyses of the apo-form and its complex with mannobiose Man 1 α(1-2) Man 2 have been performed at 1.19 and 1.65 Å resolutions, respectively. In the apo-form crystal, the protein structure is composed of the three modules similar to each other, as speculated from the tandem repeats in the sequence. Each module consists of a β-sheet of four β-strands, a long loop and a π-helix. The three modules are associated with a pseudo three-fold symmetry, in which the three β-sheets form a triangular barrel. Inside of the barrel, hydrophobic residues form a stable core. On the outer surface, a long loop with a π-helix in each module is running from the top to the bottom of the barrel. This loop and the preceding two β-strands containing the carbohydrate-binding motifs LD-QXW form a valley with a pocket for carbohydrate-binding. In the three sites of the complex-form, three mannobioses are bound, respectively. In the first pocket of the module 1, the carboxyl group of Asp15 bridges between the two hydroxyl groups (OH 3 and OH 4 ) attached to the C 3 and C 4 atoms of Man 2 , through hydrogen bonds. At the same time, OH 3 forms another hydrogen bond with the amino group of Asn28 and OH 4 forms another hydrogen bond with the hydroxyl group of Tyr23. In addition, the mannose ring of Man 2 is sandwiched between Leu25 and Tyr32 by hydrophobic interactions. To stabilize the pocket formation, Gln33 forms double hydrogen bonds with the main chain amide group at Asn28 and the carbonyl group at Pro26. In the second and the third pockets, the mannobioses are also bound in the similar ways. The structural features are completely consistent to the results of mutation experiments of these amino acid residues. The Man 1 group which is largely bent by the α(1-2) bond is protruded into the solvent region. In this pocket, the mannobiose end of D1 branch of HMTG could be accommodated in a way similar to the geometry described above, and the end of D2 or D3 branch might contact with a valley. Therefore, it is possible to speculate that each pocket accepts the D1 and D2/D3 branches of HMTG. The three pockets are located to form an almost regular triangle at a distance of 17 Å between the pockets. This separation might be possible to accept three HMTGs on a gp120 at the same time. [1] . From the crystal structures with various ligands, the non-nucleoside type inhibitors bind to the active site occupying the critical water-binding position and sustain the open form of apo-ADA. In contrast, substrate mimics do not occupy the critical position, and induce the large conformational change to the closed form. However, it is difficult to predict the binding of (+)-erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), as it possesses characteristic parts of both the substrate and the non-nucleoside inhibitors. The crystal structure shows that EHNA binds to the open form through a novel recognition of the adenine base accompanying conformational change from the closed form of the PR-ADA complex in crystalline state [2] . The open form crystal structure of the EHNA-ADA complex supports our hypothesis that the occupancy at the trigger-water-position is critical for determining the open/closed conformational alternation, rather than the nucleoside framework binding. We believe that the structural penetration of the EHNA-ADA complex and structural comparison of the other inhibitor-ADA complexes will support the discovery of novel ADA inhibitors by structure-based drug design. 
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